CompaniesInnogene Kalbiotech
Innogene Kalbiotech logo

Innogene Kalbiotech

active
Singapore, Singapore
Founded 2003
Website
About

Biologics, Biosimilars, Diagnostics

Areas of Focus

Categories

BiosimilarsDiagnosticsBiologics & BiopharmaceuticalSingapore
Team (13)
Catherine Natt
Catherine Natt
Catherine Natt
Innogene Kalbiotech
team_member
Christian Lisangan
Christian Lisangan
Christian Lisangan
Innogene Kalbiotech
team_member
Fathi Amin
Fathi Amin
Fathi Amin
Innogene Kalbiotech
team_member
Jimmy Susanto
Jimmy Susanto
Jimmy Susanto
Innogene Kalbiotech
team_member
Julito Pardamean Siahaan
Julito Pardamean Siahaan
Julito Pardamean Siahaan
Innogene Kalbiotech
team_member
Nakkiran Saravanakumar
Nakkiran Saravanakumar
Nakkiran Saravanakumar
Innogene Kalbiotech
team_member
View all 13 team members →
Clinical Trials (10)
View all

Total Trials

10

As Lead Sponsor

5

As Collaborator

5

Total Enrollment

2,654

By Phase

PHASE3: 7PHASE2: 2PHASE4: 1

By Status

COMPLETED: 7UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00702481
NCT00957086
NCT01460472
NCT02268045
Hover over trial bars to see details

Recent Trials

NCT02268045Collaborator
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
PHASE3Completed
272 participants
Started: May 31, 2013 · Completed: Jul 31, 2017
NCT01460472Collaborator
Immunotherapy With Racotumomab in Advanced Lung Cancer
PHASE3Unknown
1,082 participants
Started: Sep 30, 2010 · Completed: Sep 30, 2016
NCT01981655Collaborator
0.5M Na Lactate Solution in Acute Heart Failure (AHF)
PHASE2Completed
41 participants
Started: Dec 31, 2009 · Completed: Aug 31, 2013
NCT00957086Collaborator
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
PHASE3Active, not recruiting
710 participants
Started: Aug 13, 2009 · Completed: Jan 1, 2025
NCT01433276Lead Sponsor
Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
PHASE3Completed
71 participants
Started: Jul 31, 2009 · Completed: Jan 31, 2011
View all 10 trials →
Locations (1)
Headquarters
Singapore, Singapore
Map

Loading map...